Delivery Order SPE2DR25D2014-SPE2DR26FZ71M
- Not listed
- The Defense Logistics Agency awarded a $1,514.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,206.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Priorix vials on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract is a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,985.62 for Priorix vials on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella vaccine used to support military and federal healthcare immunization...
- The Defense Logistics Agency awarded a $1,694.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of September 4, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $24,753.00 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Priorix vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $19,416.80 delivery order to AmerisourceBergen Drug Corp for the supply of Priorix vials under a firm fixed-price contract. The award was made on September 19, 2025, with an ultimate completion date of September 22, 2025, and does not utilize a set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $14,845.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of June 10, 2025. This is a non-set-aside competitive award executed on June 9, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.10 to AmerisourceBergen Drug Corp for Priorix vials on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order was issued without a set-aside designation and represents a competitive award under the company's broader pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.18 to AmerisourceBergen Drug Corp for the supply of Priorix vials, with an ultimate completion date of November 4, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,755.30 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Priorix vials, a measles, mumps, and rubella vaccine product. This firm fixed-price contract, with a completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's facility in...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ71MDelivery Order
The Defense Logistics Agency awarded a $3,840 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials on November 17, 2025, with completion expected by November 18, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The performance location is listed as the company's corporate office in Conshohocken, Pennsylvania. Priorix is a combination vaccine providing immunization against measles, mumps, and rubella, making this delivery order part of AmerisourceBergen's extensive pharmaceutical and medical supply support to the Defense Health Agency and other military healthcare systems. As a major pharmaceutical distributor and prime vendor for federal medical procurement, AmerisourceBergen routinely fulfills delivery orders for vaccines, specialty medications, and medical supplies through its comprehensive DLA contract vehicle, which enables the company to support military healthcare programs globally across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/17/25 |